Lastly, exploring the therapeutic potential of targeting key metabolic pathways identified in this study, such as unsaturated fatty acid biosynthesis, glycerophospholipid metabolism, and nucleotide-related metabolites could lead to novel treatments for improving insulin sensitivity and metabolic health in T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.